chr3-151337803-CTTAG-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_022788.5(P2RY12):c.*10_*13delCTAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,611,834 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000051 ( 0 hom. )
Consequence
P2RY12
NM_022788.5 3_prime_UTR
NM_022788.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0510
Genes affected
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RY12 | NM_022788.5 | c.*10_*13delCTAA | 3_prime_UTR_variant | 3/3 | ENST00000302632.4 | NP_073625.1 | ||
MED12L | NM_001393769.1 | c.2251-12252_2251-12249delGTTA | intron_variant | ENST00000687756.1 | NP_001380698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RY12 | ENST00000302632 | c.*10_*13delCTAA | 3_prime_UTR_variant | 3/3 | 1 | NM_022788.5 | ENSP00000307259.4 | |||
MED12L | ENST00000687756.1 | c.2251-12252_2251-12249delGTTA | intron_variant | NM_001393769.1 | ENSP00000508695.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152094Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
152094
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250388Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135554
GnomAD3 exomes
AF:
AC:
8
AN:
250388
Hom.:
AF XY:
AC XY:
4
AN XY:
135554
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000514 AC: 75AN: 1459740Hom.: 0 AF XY: 0.0000441 AC XY: 32AN XY: 726286
GnomAD4 exome
AF:
AC:
75
AN:
1459740
Hom.:
AF XY:
AC XY:
32
AN XY:
726286
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74300
GnomAD4 genome
AF:
AC:
14
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74300
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 08, 2024 | Variant summary: P2RY12 c.*10_*13delCTAA is located in the untranslated mRNA region downstream of the termination codon. The variant allele was found at a frequency of 3.2e-05 in 250388 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.*10_*13delCTAA in individuals affected with Platelet-Type Bleeding Disorder 8 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at